PRNewsWire
19 Mar 2026, 01:44 UTC · 27w ago
Verdict
Headline takes no side. We score NVDA +0.60 across four claims — strongly bullish.
+0.60strongly bullish
More positive than 75% of ticker scores this week
What the story claims
4 claims · scored −1 bearish … +1 bullish
Basecamp Research is launching the Trillion Gene Atlas to generate and model biological data on a scale of one trillion genes, expanding known genetic diversity by 100x.
More positive than 99% of claims this week
The EDEN foundation model has demonstrated the ability to design therapeutics directly from disease prompts and achieved a 97% hit rate against priority pathogens using antimicrobial peptides.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 3 movers · tap to explore
More positive than 98% of claims this week
The Trillion Gene Atlas is being developed in collaboration with Anthropic, Ultima Genomics, and PacBio, utilizing NVIDIA's AI infrastructure.
More positive than 87% of claims this week
Basecamp Research has established a genomic data pipeline across 31 countries using off-grid DNA sequencing technologies to bypass traditional laboratory limitations.
More positive than 65% of claims this week
Which stocks this story touches
More positive than 75% of ticker scores this week
NVIDIA's AI infrastructure is powering a groundbreaking scientific initiative for biological data modeling.
More positive than 69% of ticker scores this week
PacBio is a key collaborator in the launch of the Trillion Gene Atlas to expand genetic diversity data.
More positive than 6% of relationship scores this week
[mutual] Both companies are collaborators in the Trillion Gene Atlas initiative.
More positive than 6% of relationship scores this week
[mutual] Both companies are collaborators in the Trillion Gene Atlas initiative.
More positive than 6% of relationship scores this week
[mutual] Both companies are collaborators in the Trillion Gene Atlas initiative.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
+24.8%
Price agrees with the score
$225.07 vs $180.40 close before publication (Mar 18) · not market-adjusted
NVDA chart →
